A phase I/II study of recombinant human interleukin‐12 in patients with chronic hepatitis C
Stefan Zeuzem, Uwe Hopf, Vicente Carreno, Moisés Diago, Mitchell Shiffman, Stefan Grüne, Francis J. Dudley, Ashok Rakhit, Karen Rittweger, Sing Hiem Yap, Raymond S. Koff, Howard C. Thomas – 30 December 2003 – Interleukin‐12 (IL‐12) plays a central role in mounting an effective cellular immune response directed towards elimination of intracellular pathogens.